CVS Health Corp

NYSE:CVS   3:59:58 PM EDT
106.43
+0.16 (+0.15%)
Positive Earnings Pre-Announcement

CVS Health Reports Qtrly Adjusted EPS $2.40

Published: 08/03/2022 10:58 GMT
CVS Health Corp (CVS) - Cvs Health Reports Strong Second Quarter Results, Raises 2022 Full-year EPS and Cash Flow From Operations Guidance.
Qtrly Total Revenues Increased to $80.6 Billion, Up 11.0% Compared to Prior Year.
Qtrly GAAP Diluted EPS of $2.23 and Adjusted EPS of $2.40.
Raised 2022 GAAP Diluted EPS Guidance Range to $7.23 to $7.43 From $6.93 to $7.13.
Raised FY Adjusted EPS Guidance Range to $8.40 to $8.60 From $8.20 to $8.40.
Raised 2022 Cash Flow From Operations Guidance Range to $12.5 Billion to $13.5 Billion From $12.0 Billion to $13.0 Billion.
Q2 Earnings per Share View $2.17, Revenue View $76.37 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $8.36, Revenue View $309.02 Billion -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $76.8 Billion
Adjusted EPS is expected to be $2.01

Next Quarter Revenue Guidance is expected to be $78.08 Billion
Next Quarter EPS Guidance is expected to be $1.92

More details on our Analysts Page.